HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anogenital distance at birth as a predictor of volume of the sexually dimorphic nucleus of the preoptic area of the hypothalamus and pituitary responsiveness in castrated adult rats.

Abstract
Variation in anogenital distance (AGD) in female newborn rats depends upon androgenization secondary to transplacental/transmembraneous testosterone from adjacent intrauterine male siblings. Since the size of the sexually dimorphic nucleus of the preoptic area of the hypothalamus (SDN-POA) and the degree of pituitary sensitivity to GnRH are neuroendocrine markers of neonatal androgenization, we compared these to AGD in castrated adult male and female rats. Compared to 1-day-old female rats with short AGD (less than or equal to 1.4 mm), 1-day-old female rats with long AGD (greater than 1.4 mm) had significantly larger SDN-POA volumes as adults. In contrast, LH secretion following GnRH injection did not differ in the two subgroups. Our results emphasize that some endpoints of central nervous system sexual differentiation in the adult rat are predicted by the appearance of a masculinized genital tract at birth. It follows that the complete evaluation of potential androgenizing agents will require systematic assessment of multiple morphologic and functional endpoints.
AuthorsK A Faber, C L Hughes Jr
JournalBiology of reproduction (Biol Reprod) Vol. 46 Issue 1 Pg. 101-4 (Jan 1992) ISSN: 0006-3363 [Print] United States
PMID1547306 (Publication Type: Journal Article)
Chemical References
  • Gonadotropin-Releasing Hormone
  • Luteinizing Hormone
Topics
  • Animals
  • Animals, Newborn
  • Castration
  • Female
  • Gonadotropin-Releasing Hormone (pharmacology)
  • Luteinizing Hormone (metabolism)
  • Male
  • Pituitary Gland (drug effects, metabolism)
  • Preoptic Area (anatomy & histology)
  • Rats
  • Sex Characteristics
  • Urogenital System (anatomy & histology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: